Fundraising Fox

Oxurion

2 known investors

Oxurion is a Euronext Brussels-listed Belgian company pursuing a buy-and-build strategy to build a European platform of clinical research organizations, focused on clinical data, biometrics and AI-driven research services. It serves biotech, pharmaceutical, medtech and academic sponsors across the clinical research value chain, holding a controlling stake in French CRO Axiodis and its Exagis clinical data management platform.

AI & Machine LearningBiotechHealthtech

Investors · 2

Pontifax Venture CapitalHerzeliya · $6.3M – $128M
Negma GroupreportedDubai

In the news

Oxurion plans to launch a treasury diversification strategy into digital assets under a EUR 10M indicative agreement with its main investorlive.euronext.com · Jul 2025Oxurion announces that its potential acquisition is subject to foreign investment controloxurion.com · Nov 2024Oxurion Receives EUR 1.0 Million under Amended Atlas Funding Program Total of EUR 3.5 Million in Unconditional Funding Allowing Company to Reach Topline Data from KALAHARI Trial This Yearfinance.yahoo.com · Nov 2023Oxurion Announces Amendment to Funding Program with Negma Group for EUR 6 Million in Fundingglobenewswire.com · Sep 2022Oxurion NV Business & Financial Update – H1 2021globenewswire.com · Sep 2021

Frequently asked questions

What does Oxurion do?
Oxurion is a Euronext Brussels-listed Belgian company pursuing a buy-and-build strategy to build a European platform of clinical research organizations, focused on clinical data, biometrics and AI-driven research services. It serves biotech, pharmaceutical, medtech and academic sponsors across the clinical research value chain, holding a controlling stake in French CRO Axiodis and its Exagis clinical data management platform.
Who are Oxurion's investors?
Oxurion's investors include Pontifax Venture Capital, Negma Group.